Christoph Wohlkoenig

Author

Also Known As

C Wohlkoenig, C. Wohlkoenig, Christoph Wohlkoenig

Publications

515

Citations

H-Index

Concepts

All Affiliations

Christoph Wohlkoenig is an author at Medical University of Graz specializing in radiation oncology, lung cancer, and medicine.

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	321
2	Cell Biology	3	3	288
3	Cancer Therapeutics	2	2	92
4	Pathology	1	1	33
5	Cancer Cell Biology	1	1	27

Christoph Wohlkoenig

Publications

441

Citations

H-Index

Page 1

	Year	Citations
PCK2 activation mediates an adaptive response to glucose depletion in lung cancer Katharina Leithner, Andelko Hrzenjak, Martin Trötzmüller, Oncogene Tumor BiologyOncologyMedicinePck2 ActivationAdaptive Response	2014	202
Panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma cells via HIF-1α destabilization Carina Fischer, Katharina Leithner, Christoph Wohlkoenig, Molecular Cancer	2015	74
Hypoxia-induced cisplatin resistance is reversible and growth rate independent in lung cancer cells Christoph Wohlkoenig, Katharina Leithner, Alexander Deutsch, Cancer Letters OncologyGrowth RateMedicineHypoxia-induced Cisplatin ResistanceBronchial Neoplasm	2011	59
Peroxisome Proliferator–Activated Receptor–β/δ, the Acute Signaling Factor in Prostacyclin-Induced Pulmonary Vasodilation Yingji Li, Michelle Connolly, Chandran Nagaraj, American Journal of Respiratory Cell and Molecular Biology	2011	46
Nuclear and cytoplasmic death receptor 5 as prognostic factors in patients with non-small cell lung cancer treated with chemotherapy Katharina Leithner, Elvira Stacher, Robert Wurm, Lung Cancer Prognostic FactorsMedicineCell DeathPathologyBronchial Neoplasm	2008	33
TR3 is involved in hypoxia-induced apoptosis resistance in lung cancer cells downstream of HIF-1α Christoph Wohlkoenig, Katharina Leithner, Andrea Olschewski, Lung Cancer Cancer ResearchOncologyLung InflammationHypoxia-induced Apoptosis ResistanceMedicine	2017	27

Page 1